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Abstract
Background: There are two biotypes of feline coronavirus (FCoV): the self-limiting feline enteric coronavirus (FECV)
and the feline infectious peritonitis virus (FIPV), which causes feline infectious peritonitis (FIP), a fatal disease
associated with cats living in multi-cat environments. This study provides an insight on the various immune
mediators detected in FCoV-positive cats which may be responsible for the development of FIP.
Results: In this study, using real-time PCR and multiplex bead-based immunoassay, the expression profiles of several
immune mediators were examined in Crandell-Reese feline kidney (CRFK) cells infected with the feline coronavirus
(FCoV) strain FIPV 79–1146 and in samples obtained from FCoV-positive cats. CRFK cells infected with FIPV 79–1146
showed an increase in the expression of interferon-related genes and pro-inflammatory cytokines such as MX1, viperin,
CXCL10, CCL8, RANTES, KC, MCP1, and IL8. In addition, an increase in the expression of the above cytokines as well as
GM-CSF and IFNγ was also detected in the PBMC, serum, and peritoneal effusions of FCoV-positive cats. Although the
expression of MX1 and viperin genes was variable between cats, the expression of these two genes was relatively higher
in cats having peritoneal effusion compared to cats without clinically obvious effusion. Higher viral load was also detected
in the supernatant of peritoneal effusions compared to in the plasma of FCoV-positive cats. As expected, the secretion of
IL1β, IL6 and TNFα was readily detected in the supernatant of peritoneal effusions of the FCoV-positive cats.
Conclusions: This study has identified various pro-inflammatory cytokines and interferon-related genes such as MX1,
viperin, CXCL10, CCL8, RANTES, KC, MCP1, IL8, GM-CSF and IFNγ in FCoV-positive cats. With the exception of MX1 and
viperin, no distinct pattern of immune mediators was observed that distinguished between FCoV-positive cats with and
without peritoneal effusion. Further studies based on definitive diagnosis of FIP need to be performed to confirm the
clinical importance of this study.
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Background
Feline coronavirus (FCoV) can be divided into two
biotypes: the ubiquitous feline enteric coronavirus
(FECV) which often causes self-limiting diarrhea, and
the feline infectious peritonitis virus (FIPV), the mutated
form which causes fatal disease in cats [1, 2]. The widely
accepted ‘internal mutation’ theory describes that muta-
tions in FECV give rise to FIP de novo. In addition, it
was suggested that these mutations occur in the mono-
cytes, rather than the intestinal epithelial cells where the
FECV first enters the host [3, 4]. FCoV travels to organs
and tissues through monocyte-associated viremia where
it is later disseminated in the endothelial venules of the
serosa, omentum, pleura, meninges and uveal tract
(reviewed in [1, 2]).
Currently, there are no specific markers to distinguish
the two biotypes, thus making the diagnosis of feline
infectious peritonitis (FIP) difficult. Although several
studies have reported several point mutations in the S
gene that are associated with occurrence of FIPV, it
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remains unclear whether the mutations contributed
solely to the development of FIP [5–7]. Therefore, ante-
mortem confirmation of FIP remains a challenging task
in clinical research of FIP.
Information on the immunopathogenesis and the role of
cytokines, and immune mediators in FCoV infection are
relatively sparse. Although it is generally known that
FECV causes self-limiting disease, cats can become per-
sistent shedders contributing to the transmission of the
disease (reviewed in [1, 2]). However, only approximately
5% of cats harboring FECV actually develop FIP [1, 8].
The exact nature of this immunity is still unknown
although the development of FIP has been postulated to
correlate with the magnitude of immune responses, as
cats with robust cell-mediated immune (CMI) response
have been found to resist the disease [9]. In contrast,
humoral response does not seem to be beneficial and
could lead to the dissemination of the virus through com-
plement activation via formation of immune complexes
and vasculitis associated with type III hypersensitivity
(reviewed in [1, 2]). This would then lead to effusive
FIP (wet form), the most commonly reported form of
FIP due to the obvious sign of peritoneal effusion.
The non-effusive form of FIP is associated with
partial CMI response in the individual cat to contain
the virus leading to the formation of granulomas con-
taining macrophages, which could then be replaced
by B cells and plasma cells [10, 11].
To date, there are no specific immune markers that
could distinguish FECV from FIPV infections. However,
the observed cytokine patterns are different between
asymptomatic FCoV-infected cats and those with clinical
signs of FIP [12]. Asymptomatic FCoV-infected cats
generally show higher IL10 in the spleen, suggesting the
ability to control excessive inflammation triggered by
macrophages. Furthermore, lymphocyte depletion has
been indicated as one of the hallmarks of FIP and
postulated to be induced by excessive production of TNFα
[13–15]. In contrast, high IFN γ and IL 1β production has
been associated with protection against FIP [16]. Increase
in Th1-like cytokines such as IL12/p40 and IFNγ, which
were associated with the decrease of IL4 in the lymphoid
tissue, has been observed in cats experimentally infected
with FIPV [13]. Furthermore, previous studies showed de-
regulation of different mediators, illustrated by the upreg-
ulation of pro-inflammatory cytokines such as IL1β, IL6,
TNFα, MIP1α, RANTES, and IFNγ in peritoneal effusions
and serum samples of FIP clinical cases [17–19].
Recently, we used a transcriptomic approach by next-
generation sequencing of RNA from Crandell-Reese
feline kidney (CRFK) cells infected with the FCoV strain
FIPV 79–1146 to elucidate the complex interaction
between the virus and host cells in vitro [20, 21]. Results
revealed that, during the first 3 h of infection, at least 96
transcripts associated with immune responses (e.g. ISGs,
MX1, RSAD2, A3C, ID1, CRIP1, TRIM25 and MDA5),
apoptosis (ID1, ATF3, TNFα, and RNF7), and pro-
inflammatory responses (e.g. PD-L1, CCL8, CXCL10 and
CCL17) were downregulated. Only a few genes, namely
PD-1, PD-L1 and A3H, has been previously charac-
terized in a study on FCoV-infected CRFK cells and
expression profiles in peripheral blood mononuclear
cells (PBMC) of cats diagnosed with FIP [20].
Characterization of additional immune mediators that
modulate innate and acquired immune responses will
increase our understanding of their involvement during
FIPV infection. The objective of this study was to inves-
tigate the immune mediator profiles in CRFK-infected
cells and FCoV-positive cats. Both gene and protein
expression profiles were determined by quantitative
real-time PCR (qPCR) and multiplex bead-based assays.
Methods
In vitro analysis of FCoV-infected cells
TCID50 of the FCoV strain FIPV 79–1146 (ATCC®
VR2202) [22] was determined using endpoint dilution
assay. Virus infectivity was confirmed by RT-PCR (Bioline,
UK) detecting the FCoV conserved 3′ untranslated region
(3′-UTR) [23]. To prepare a sufficient amount of infected
cells at different time points, two confluent 75 cm2 flasks
of CRFK cells (ATCC® CCL-94™) were inoculated at each
time point with 3 ml TCID50/ml (MOI = 0.1) of FIPV 79–
1146 and the virus inoculum was left in the culture. At 3,
12, 24, 48 and 72 h post-inoculation (hpi), the cells were
trypsinized and cell pellets were collected upon centrifu-
gation. The uninfected flask was designated as 0 hpi. The
cell pellets were stored at −80 °C until further use for virus
and immune mediator detection by real-time PCR and
multiplex bead-based immunoassay.
Selection criteria for FCoV-positive cats
Before performing the in vivo phase of the study,
approval for handling and sampling cats was obtained
from the Institutional Animal Care and Use Committee
(IACUC), Faculty of Veterinary Medicine, Universiti
Putra Malaysia (UPM) with the reference number UPM/
IACUC/AUP-R040/2014. The status of FCoV infection
was evaluated in cats that were presented to the University
Veterinary Hospital (UVH), UPM, using Biogal’s Immuno-
comb Antibody Test Kit (Biogal-Galed Laboratories,
Israel) to determine the antibody titer, followed by reverse
transcriptase quantitative PCR (RT-qPCR) to detect the
presence of FCoV in the serum [23]. Combscale S value
was used as a colorimetric indicator for the determination
of anti-FCoV antibody titer, where cats with antibody ti-
ters ≥ S2+ were chosen for further analysis [24]. In
addition, cats were also screened serologically for Feline
Immunodeficiency Virus (FIV) and Feline Leukemia Virus
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(FELV) using the SNAP FIV/FELV Combo test (IDEXX
Laboratories, USA) according to the manufacturer’s
protocol. Cats with high antibody levels against FCoV
(titer ≥ S2+) and that are seronegative for FIV and FELV
were selected and further underwent hematology evalu-
ation. In addition to that, the presence or absence of
peritoneal effusion was also evaluated in these selected
cats. Post-mortem examination and follow-up analysis
were not carried out to arrive at definitive diagnosis of
FIP. Healthy seronegative FIV/FELV cats with absence of
antibody titer against FCoV were considered as negative
control cats.
Blood collection for preparation of PBMC and plasma
A total of 2.5 ml blood was collected from FCoV anti-
body titer ≥ S2+, FIV- and FELV- cats. The collected
blood samples were immediately divided into two tubes
for different purposes. First, 0.5 ml of blood was stored
in clot activator tubes (BD Vacutainer® Tubes with BD
hemoguard closure, USA) on ice and kept at 4 °C for
serum separation. The remainder of the blood was trans-
ferred into EDTA tubes (BD Vacutainer® Tubes with BD
hemoguard closure, USA) for PBMC isolation and
plasma collection. The collected serum was stored at
−80 °C for multiplex bead-based immunoassay. Isolation
of PBMC was performed using Ficoll-Paque PLUS (GE
Healthcare Life Science, USA) following the steps
provided by the manufacturer. Plasma and PBMC were
collected separately and stored at −80 °C until further
use in real-time PCR for measuring viral load and
mRNA expression of immune-related genes.
Peritoneal effusion
Peritoneal effusion (PE) samples were collected from
FCoV-positive cats and centrifuged at 400×g for 10 min
at 4 °C. The obtained cell pellets were used for detecting
expression of immune-related genes using real-time
PCR, whereas the supernatants were used for virus
detection using RT-qPCR and for measuring cytokine
and chemokine levels using multiplex bead-based
immunoassay.
RNA extraction
Cellular RNA was extracted from the CRFK, PBMC and
PE cells using the RNeasy Mini Kit, which includes
DNase treatment (Qiagen, Germany), following the
protocol supplied by the manufacturer. Viral RNA was
extracted from the cell culture pellet, plasma, and super-
natant of the PE (PES) using the Viral Nucleic Acid
Extraction Kit 2 (Geneaid, Taiwan) according to the
manufacturer’s instructions. The concentration and
quality of the extracted RNA were analyzed using a
BioSpectrometer (Eppendorf, Germany). The extracted
RNA samples (100 ng/μl) were used immediately to
synthesize cDNA or kept at −80 °C for future usage.
Detection of viral load by SYBR green-based real-time PCR
cDNA was synthesized using the SensiFAST™ cDNA Kit
(Bioline, UK), as instructed by the manufacturer. Virus
quantification was performed using SYBR Green-based
real-time PCR as described previously with a slight
modification [25]. Briefly, quantitative real-time PCR
(qPCR) was performed in a 20 μl reaction consisting of
1 μl cDNA, 1 μl forward primer (1 μmol), 1 μl reverse
primer (1 μmol), 7 μl nuclease-free water and 10 μl 2×
SensiFAST SYBR® No-ROX mix (Bioline, UK). The
qPCR reaction was performed using the CFX96 Touch
TM Real-Time PCR Detection System (Bio-Rad, USA)
with the following cycling conditions: one cycle at 95 °C
for PCR activation and 40 cycles of denaturation at 95 °C
for 5 s, annealing at 60 °C for 10 s, and extension at 70 °C
for 20 s. Detection of viral load was done by absolute
quantification based on a standard curve generated from
the serial dilution of a cDNA template. Viral load was
expressed as viral copy number following a formula
described previously [26].
Detection of immune-related mRNA expression by
TaqMan-based real-time PCR
The expression of five immune-related genes, namely
CCL8 (MCP2), viperin (RSAD2), CXCL10, MX1, and
CCL17, and one reference gene (GAPDH) was measured
by TaqMan-based real-time PCR (qPCR). The forward
primers, reverse primers and TaqMan MGB probes were
designed based on the Felis catus genome sequence [27].
The sequences of the primers and probes were designed
using the CLC genomic workbench software, while pri-
mer characteristics were analyzed using Primer3 (http://
bioinfo.ut.ee/primer3-0.4.0/) and Basic Local Alignment
Search Tool (BLAST) to confirm alignment with more
than 80% of the related gene in the Felis catus genome
(Applied Biosystem, USA) (Table 1). cDNA was prepared
using the Tetro cDNA Synthesis Kit (Bioline, UK) ac-
cording to the manufacturer’s protocol with a slight
modification, in which specific forward and reverse
primers for each gene were used instead of random
hexamers. The RNA extracted from FIPV-infected CRFK
cells at 48 hpi was used to optimize the real-time PCR
assay before the assay was used to measure expression
in the clinical samples obtained from FCoV-positive cats.
Using serially diluted cDNA of each gene, the designed
primer sets produced specific amplification with high
PCR efficiency. Furthermore, primers for each gene were
designed spanning two different exons to ensure
specificity.
qPCR was performed using the TaqMan Fast Advanced
Master Mix (Life Technologies®, Applied Biosystems,
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USA) according to the manufacturer’s protocol. 20 μl re-
actions were prepared as follows: 1 μl cDNA template,
0.5 μl forward primer (450 ηM), 0.5 μl reverse primer (450
ηM), 1 μl probe (250 ηM), 7 μl nuclease-free water and
10 μl of Fast Advanced Master Mix. The Taqman Fast
Advanced Master Mix consisted of AmpliTaq Fast DNA
Polymerase, Uracil-N-glycosylase (UNG), dNTPs with
dUTP, ROX dye, and optimized buffer components. RT-
qPCR was performed on the CFX96 Touch TM Real-
Time PCR Detection System (Bio-Rad, USA) with the fol-
lowing steps: initial UNG incubation at 50 °C for 2 min
and PCR activation at 95 °C for 20 s, followed by 40 cycles
of denaturation at 95 °C for 5 s, annealing at optimized
temperature for 10 s (Table 1), and extension at 72 °C for
20 s. The PCR efficiency of GAPDH, CXCL10, MX-1,
viperin, CCL17 and CCL8 was 100, 99, 101, 102, 100 and
100%, respectively. For data interpretation, relative expres-
sion analysis (ΔΔCq) followed by analysis of variance
(ANOVA) (p < 0.05) were carried out to determine the ex-
pression changes of target genes across different time
points. Relative expression of the different immune-
related genes were normalized to GAPDH and the nega-
tive controls.
Detection of immune-related protein expression by multiplex
bead-based immunoassay
Measurement of 19 different immune-related protein
expression was performed using the feline cytokines/
chemokine magnetic bead-based panel immunoassay,
FCYTOMAG-20 K FCYTMAG-20 K-PMX (MILLIPLEX
MAP Kit, EMD Millipore Corporation, USA) following
the manufacturer’s instructions. The assay’s principle of
quantitative analysis was based on the standard provided
in the kit. The standard was a mixture of all immune-
related proteins at certain concentrations prepared by
dilution as described by the kit. Hence, the concentra-
tions of immune-related proteins in the samples were
measured using the standard curve generated by the
standard. The prepared incubated plates (containing
samples, standard and quality controls) were read on
a Luminex analyzer (MAGPIX). Data obtained from
the analyzer were analyzed by the MILLIPLEX analyst
v5.1 software using five parameters logistic regression
(EMD Millipore).
Statistical analysis
Data generated from this study were represented as
means ± standard error of the mean (SEM). Statistical
package for the social sciences (SPSS) version 22 was
used to perform factorial analysis of variance (ANOVA)
at 0.05 levels of significance for both the in vitro and in
vivo experiments. Duncan test was used for post hoc
analysis between the groups.
Results
Detection of viral load
Viral load in the infected cells was detected based on the
3′ UTR region of FIPV using SYBR green-based real-time
PCR. An increase in viral load was detected at different
time points, with the peak viral load of 1012.54 occurring at
48 hpi, while the lowest viral load was detected at 3 hpi
(Table 2). Total RNA obtained from the CRFK cells at 72
hpi was used to optimize the real-time PCR. The real-time
PCR assay has a PCR efficiency of 100%.
Expression profiles of immune-related genes in FIPV
79–1146-infected cells
All the analyzed immune-related genes showed significant
(p < 0.05) changes in expression levels at different time
points following infection with FCoV strain FIPV 79–
1146. These genes were selected based on transcriptome
data from our previous study on CRFK cells infected with
FIPV 79–1146 [14]. In this study, we confirmed the upreg-
ulation of these genes at 3 hpi using Taqman real-time
PCR. CCL8 and MX1 showed peak expression levels at 48
hpi, while CXCL10 and viperin showed the highest
Table 1 TaqMan primers, MGB probes and accession numbers of the analyzed immune-related genes
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expression at 72 hpi (Table 3). Although the expression of
viperin was upregulated at 48 and 72 hpi, its expression
was downregulated at 3 and 12 hpi (Table 3).
Detection of immune-related proteins in FIPV 79–1146-
infected CRFK cells
A total of 19 different immune-related proteins were
analyzed by a bead-based multiplex immunoassay at
different time points, following infection with FIPV
79–1146. The panel of proteins was chosen since it
comprised of mediators with known functions in
antiviral immunity, modulation of pro-inflammatory
responses and regulation of viral-induced apoptosis.
Out of the 19 immune-related proteins, only IL8
(CXCL8), KC (CXCL1), RANTES (CCL5) and MCP1
(CCL2) were detected in the CRFK-infected cells
(Table 4). We were unable to detect the expression of
other proteins, most likely due to the non-
hematopoietic origin of CRFK cells whereby they did
not secrete the proteins and/or the expression levels
were too low beyond the detection limit of the assay.
FIPV infection of CRFK cells caused a significant
modulation in the expression of the detectable cytokines,
with peak expression detected at 48 hpi (CCL2 and
CCL5) or 72 hpi (CXCL1 and CXCL8). However, CXCL8
and CCL5 were downregulated at 3 hpi (p > 0.05). CCL2
showed the least changes in expression compared to
other cytokines following FIPV 79–1146 infection.
Detection of immune-related protein expression in
FCoV-positive cats
Clinical features of the cats
The sampling of FCoV-positive cats was carried out at the
University Veterinary Hospital-Universiti Putra Malaysia
(UVH-UPM) over 1 year. Out of 150 cats, a total of 15 cats
of different sex, age and breed that tested positive for high
(≥ S + 2) FCoV antibody titer and FCoV RNA by RT-PCR
but negative for FELV and FIV antibodies were considered
for this study (Table 5). In addition, among the 15 FCoV-
positive cats, nine cats were presented with peritoneal effu-
sions, hence they were categorized into the effusive cohort.
The remaining six cats were either asymptomatic (cat 6, 14
and 15) or having signs associated with non-effusive FIP
(cat 2, 3 and 16) (Table 5).
Hematology examination of the nine cats with effusions
showed evidence of thrombocytopenia, hyperbilirubine-
mia, hyperglobulinemia and hypoalbuminemia, with three
of these cats also having lymphopenia and icterus. In
addition, the cats had albumin/globulin (A: G) ratios of
between 0.3–0.6. Cat 1 represents three healthy FCoV-
negative cats aged 2–4 years that also tested negative for
FIV and FELV antibodies.
Detection of FCoV load in FCoV-seropositive cats
FCoV was quantified by RT-qPCR in blood plasma and
supernatant of the peritoneal effusion (PES) taken from
the FCoV-seropositive cats. All of the cats, except for
the FCoV-seronegative cats, had positive viral load in
the plasma and PES (Table 6). Furthermore, the level of
viral load in the PES was significantly higher (p < 0.05)
than in the plasma for the majority of the cats (Table 6).
Only two cats (cats 10 and 11) exhibited higher viral
load in the plasma. Almost all cats with peritoneal effu-
sions had higher plasma viral load (p < 0.05) compared
to cats without peritoneal effusion.
Table 2 Intracellular FCoV load in CRFK cells at different time
points post infection
Time points (hpi) FCoV copy number
[Mean ± SEM (log10)]
Intracellular
0a -
3b 5.22 ± 0.12
12d 10.28 ± 0.06
24c 6.33 ± 0.02
48f 12.54 ± 0.34
72e 11.83 ± 0.05
Note: Different alphabets indicate significant difference (p < 0.05) following
Duncan post hoc analysis of three replicates from three
independent experiments
Table 3 Relative expression of immune-related genes following FIPV 79–1146 infection of CRFK cells
Time points (hpi) CCL8 (MCP2) CXCL10 (IP10) CCL17 MX1 Viperin (RSAD2)
0 1 ± 0a 1 ± 0a 1 ± 0a 1 ± 0a 1 ± 0c
3 21.67 ± 0.57d 13,341.2 ± 197.75c 39.68 ± 1.61e 4.49 ± 0.62c −13.04 ± 0a
12 3.41 ± 0.07b 8712.95 ± 343.29b 3.56 ± 0b 9.16 ± 1.27d −7.82 ± 0.02b
24 4.92 ± 0.04c 1,835,241.44 ± 7662.16d 22.87 ± 0.69d 2.69 ± 0.11b 5.72 ± 0.03d
48 40,322.18 ± 14.38f 8,569,241.92 ± 44,483.37e 39.86 ± 0.6e 900.72 ± 4.25f 353.53 ± 1.82e
72 21,651.02 ± 510.17e 8,776,535.79 ± 30,986.02e 8.51 ± 0.44c 517.06 ± 5.38e 583.3 ± 9.86f
Note: Data are presented as means ± SEM of three replicates from two independent experiments. Different alphabets above the data indicate significant
difference following Duncan post hoc comparison of each column (p < 0.05). Relative expression (ΔΔCq) was calculated by normalizing with the reference gene
(GAPDH) and the negative controls
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Expression profiles of immune-related genes in PBMC
The expression profiles of five immune-related genes,
which were analyzed following in vitro infection of CRFK
cells, were also analyzed in the PBMC and PE cells
isolated from the FCoV-positive cats. In addition to
normalization to GAPDH, the relative expression of the
immune-related genes were normalized to the negative
controls. As shown in Table 7, expression of all the genes
except for CCL17 were detected in the PBMC of the sam-
pled cats. However, gene expression levels varied among
the cats. Most of the cats did not express or expressed
very low levels of CCL8 and CXCL10 compared to healthy
cats, except for cats 2, 3 and 5.
The expression of MX1 was detected in all FCoV-
seropositive cats but not in healthy cats, and higher ex-
pression levels were detected in FCoV-positive cats with
effusions (Table 7). Although viperin functions as an IFN-
induced antiviral protein, similar to MX1, different pat-
terns of viperin expression was observed. In addition, five
out of six cats without signs of effusion showed downreg-
ulation of viperin compared to control cats (Table 7).
Nevertheless, in cats with effusions, expression of viperin
showed a trend similar that of MX1. In addition, a
majority of the FCoV-positive cats with effusions showed
markedly elevated expression levels of MX1 and viperin.
As expected, the FCoV-negative cats did not express any
of the analyzed immune-related genes, except for viperin.
Expression profiles of immune-related genes in peritoneal
effusion cells
No distinct expression pattern was observed in the cellular
component of PE collected from FCoV-positive cats
(Table 8). However, high expression of CCL17 was
detected in PE samples from three out of eight FCoV-
Table 4 Measurement of immune-related protein concentrations (pg/ml) in FIPV 79–1146-infected CRFK cells at different time
points
Time points (hpi) CXCL8 (IL8) CXCL1 (KC) CCL5 (RANTES) CCL2 (MCP1)
0 465.33 ± 2.14b 9.23 ± 0.02a 22.63 ± 0.27c 913.03 ± 0.005a
3 166.75 ± 25.74a 28.55 ± 9.21b 8.35 ± 0.004a 960.84 ± 0.005b
12 444.32 ± 3.03b 8.32 ± 0.01a 31.18 ± 0.61d 923.22 ± 0.004a
24 1564.5 ± 45c 151.55 ± 9.98c 16.75 ± 0.73b 994.92 ± 7.38b
48 1499.5 ± 82.34c 119.02 ± 12.54c 2470 ± 114.67f 1068.5 ± 41.67c
72 2551 ± 93.33d 334.83 ± 9.49d 126.6 ± 2.4e 1050 ± 0.001c
Note: Data are represented as means ± SEM of three replicates from two independent experiments. Different alphabets above the data indicate significant
difference following Duncan post hoc comparison of each column (p < 0.05). Peak expression levels of the cytokines were detected at 48 and/or 72 hpi
Table 5 Demographic and clinical features of the cats considered for this study
ID Age Sex Breed FCoV titer FELV /FIV titer Body temperature °C Peritoneal effusion A:G ratio
1 2–4 years F DSH 0 − − − NA
2 1 year M Persian S2+ − N/A − 0.6
3 7 months M Persian S3+ − N/A − NA
6 8 months F DSH S5+ − N/A − NA
14 2 years M DSH S5+ − N/A − NA
15 2 years F DSH S5+ − N/A − NA
16 8 months F Persian S5+ − 37.9 − 0.3
4 2 years M DSH S3+ − N/A + NA
7 7 months M Maine coon S5+ − 37.3 + 0.3
8 9 months M DSH S4+ − 39.2 + 0.4
9 3 years M DSH S5+ − 38.6 + 0.6
5 2 years M DSH S5+ − 39.8 + 0.3
10 8 months M DSH S5+ − N/A + 0.3
11 10 months M Maine coon S4+ − 40.5 + 0.3
12 1 year M Maine coon S4+ − 38.3 + 0.5
13 11 months M Persian S5+ − 40.0 + 0.4
Note: NA not available, DSH Domestic short hair, A:G Albumin/Globulin, F Female, M Male, FCoV scoring of S2+ titer low positive reaction, ≥S3+ titer positive
reaction, ≥S5+ titer high positive reaction
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positive cats with effusions. Meanwhile, cat 8, which
showed the highest expression of CCL17, also exhibited
the highest expression of MX1 and viperin as well. In
addition, most of the cats that expressed MX1 also
expressed viperin and CXCL10, suggesting the involve-
ment of interferon-induced antiviral proteins; however,
their expression levels varied significantly among different
cats.
Expression profiles of immune-related proteins in serum
and peritoneal effusion supernatant
MILLIPLEX analysis of the serum and PES from the
FCoV-positive cats revealed that all 19 immune-related
proteins were detectable (Tables 9 and 10). However, no
clear pattern was observed between the different levels of
cytokines in cats with or without the presence of periton-
eal effusions. Nevertheless, the expression of the immune-
related proteins was higher in PES than in serum.
Although no common pattern of expression was seen
among the FCoV-positive cats, detected levels of the dif-
ferent immune-related proteins in serum were higher in
cats with peritoneal effusions compared to non-effusive
FCoV-positive cats. The expression of pro-inflammatory
cytokines and chemokines, such as GM-CSF, IFNγ, IL8,
KC, RANTES, and MCP1, was readily detected in the
serum of FCoV-positive cats (Table 9). The expression of
IL1β and IL6 was not detected in the serum of the major-
ity of the cats; however, these cytokines were detected in
Table 6 Detection of FCoV load in plasma and supernatant of
peritoneal effusion
Cat status Cat ID FCoV copy number
[Mean ± SEM (log10)]
Plasma PES
Negative controls 1* - a -
Non effusive 2 9.6 ± 0.05b -
3 10.73 ± 0.06cdefg -
6 10.41 ± 0.82cde -
14 10.25 ± 0.17c -
15 10.53 ± 0.01cde -
16 10.92 ± 0.34cdefgh -
Effusive 4 11.06 ± 0.28efghi N/A
7 11.31 ± 0.33ghi 14.16 ± 0.05l
8 10.74 ± 0.09cdefg 13.01 ± 0.04k
9 11.72 ± 0.06ij 12.13 ± 0.18j
5 11.28 ± 0.31fghi 13.21 ± 0.05k
10 12.13 ± 0.35j 10.6 ± 0.65cdef
11 10.99 ± 0.07defgh 10.31 ± 0.09cd
12 11.57 ± 0.28hij 11.69 ± 0.19ij
13 10.78 ± 0.74cdefg 12.02 ± 0.05j
N/A not available, PES supernatant of peritoneal effusion
*Cat 1 represents three healthy cats as negative controls
Note: Data are presented as means ± SEM of three replicates. Different
alphabets denote significant difference (p < 0.05) following Duncan post
hoc analysis
Table 7 Relative expression profiles of immune-related genes in PBMC of FCoV-positive cats
Cat status Cat ID CCL8 (MCP2) CXCL10 (IP10) MX1 Viperin (RSAD2)
Negative 1* ND ND ND 1 ± 0bc
Non-effusive 2 ND 18.67 ± 0.33b 6.79 ± 1.8e −1.88 ± 0.27bc
3 16.32 ± 5.48c ND 0.91 ± 0.1cd ND
6 ND ND 0.03 ± 0a −86.21 ± 0.01a
14 0.42 ± 0.02a ND 1.45 ± 0.36d −28.01 ± 0.02b
15 ND ND 0.58 ± 0.04c −94.34 ± 0.01a
16 ND ND 0.32 ± 0.07b −39.84 ± 0.02b
Effusive 4 ND ND 0.05 ± 0a ND
7 0.1 ± 0.05a 0.23 ± 0.22a 13.62 ± 5.07fg 4.87 ± 1.39cd
8 ND ND 3773.07 ± 67.71j 437.28 ± 31.23f
9 ND ND 7309.7 ± 52.55k 50.48 ± 3.44e
5 1.08 ± 0.38b 19.17 ± 0c 19.14 ± 0.02gh 4.95 ± 0.31cd
10 ND ND 56.48 ± 13.47i 7.91 ± 5.25de
11 ND ND 6.79 ± 0.74ef −3.35 ± 0.17c
12 ND ND 16.37 ± 5.13g 1.83 ± 0.45bcd
13 ND ND 26.9 ± 1.61h 10.16 ± 1.08de
ND Not detected
*Average expression of three healthy cats as negative controls. Relative expression (ΔΔCq) was calculated by normalizing to the reference gene (GAPDH) and
negative controls
Note: Data are presented as means ± SEM of three replicates. Different alphabets indicate significant difference following Duncan post hoc comparison of each
column (p < 0.05)
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the PES of cats with peritoneal effusions (Table 10). TNFα
production was detected in both FCoV-positive and nega-
tive cohorts. The production of this cytokine in the con-
trol cats could be due to an inflammatory process
unrelated to FCoV infection, such as physiological stress
[28]. In addition, the pro-inflammatory cytokine IL-18
was not consistently detected in both serum and PES.
Unlike other immune-related proteins, serum levels of
stem cell factor (SCF) were lower in the FCoV-positive
cats compared to the control cats (Table 9).
Discussion
Feline infectious peritonitis (FIP) is one of the leading
causes of death among young cats [1]. Since FIP is an
immune-mediated viral disease, studies using immuno-
logical approaches are crucial for a better understanding
of the illness, particularly by using clinical samples of
FIP cases before further studies utilizing experimental
infection in cats could be justified. Detection of FCoV
antigen in affected tissues by immunohistochemistry
remains the gold standard in the confirmation of FIP [2].
One of the limitations of this study is that definitive
confirmation of FIP was not made due to the unavailabi-
lity of post-mortem samples. Therefore, the cats were
selected based on their FCoV antibody and antigen status.
In addition, the selected FCoV-positive cats were grouped
according to the presence of peritoneal effusions at the
time of clinical evaluation. Although we could not confirm
the status of FIP in these cats, this study provides a pre-
liminary examination on the array of immune mediators
that may be involved in the development of FIP. In this
study, more than 20 immune mediators were characte-
rized following FIPV 79–1146 infection of CRFK cells and
in FCoV-positive cats. Different expression profiles of im-
mune mediators were detected in FIPV 79–1146-infected
CRFK cells and those from FCoV-positive cats. Further-
more, the CRFK cells were used to optimize the real-time
PCR detection of the different immune-related genes and
to detect interferon-related genes during viral infection.
Based on an NGS transcriptomic study, we showed
that pro-inflammatory and interferon-related genes,
namely CCL8 (MCP2), CXCL10 (IP10), CCL17, MX1
and viperin (RSAD2), were upregulated in FIPV 79–
1146-infected CRFK cells [14]. In this study, we con-
firmed the upregulation of these genes using Taqman
real-time PCR (Table 2); however, detected levels of
expression varied, which could be due to the differences
in the sensitivity of these different platforms. One of the
genes of interest that was highly upregulated and associ-
ated with an increase in viral load is MX1, an interferon-
induced GTP-binding protein. Previous studies have
shown that MX1 is an interferon-inducible protein
found in humans and various animals that mediates
resistance against RNA viruses [29]. In this study, we
showed that mRNA expression of MX1 was significantly
upregulated at 48 and 72 hpi and found to be correlated
with the viral load at 48 hpi (Tables 2 and 3). Previous
studies have also shown that the antiviral role of this
gene is related to IFNα and β (IFN type 1) induction and
GTPase pathways [19]. Similar to MX1, RSAD2, which
is also known as viperin, is a gene that encodes for an
IFN-induced antiviral protein [30]. However, unlike
MX1, which is activated by type I IFN, viperin is induced
by different types of IFN [31, 32]. In fact, the expression
of viperin can be induced by double-stranded RNA ana-
logs such as poly I:C, lipopolysaccharides and by infec-
tion with a broad range of both RNA and DNA viruses,
indicating the diverse role of viperin during infection
[31, 32]. The importance of this finding is not clear;
nevertheless, studies have shown that viruses such as
Japanese Encephalitis Virus (JEV) [33] and Dengue Virus
type 2 (DENV-2) [34] can downregulate antiviral innate
immune responses such as viperin and other IFN-
inducible protein expression [31, 32]. Further studies are
required to measure type I IFN levels in cats with FIP.
The clinical relevance of the observed variations in
MX1 and viperin expression to the development of
FIP is unknown. However, a study has shown that
expression of viperin is crucial for optimal Th2 cell
Table 8 Relative expression profiles of immune-related genes in cells from peritoneal effusion
Cat ID CCL8 (MCP2) CXCL10 (IP10) CCL17 MX1 Viperin (RSAD2)
7 1.77 ± 0.29d 2.14 ± 0e 0.37 ± 0.19bc 1.65 ± 0.09c 2.14 ± 0e
8 0.29 ± 0.06b 0.57 ± 0.2bc 18.95 ± 16.6cd 11.24 ± 0.82e 13.31 ± 1.98f
9 0.46 ± 0.04bc 0.36 ± 0.1b 12.69 ± 6.01d 0.58 ± 0.02b 0.03 ± 0a
5 0.12 ± 0.02a 0.06 ± 0.01a 0.37 ± 0.18cd 0.61 ± 0.03b 0.34 ± 0.02b
10 1.43 ± 0.11d 0.64 ± 0.1bcd 0 ± 0a 1.36 ± 0.1c 0.79 ± 0.12c
11 0.1 ± 0.04a 0.85 ± 0.07cd 9.18 ± 3.87d 0.21 ± 0.03a 1.15 ± 0.13d
12 4.62 ± 0.08e 2.21 ± 0.38e 0.03 ± 0.03ab 4.7 ± 0d 1.97 ± 0.34e
13 0.79 ± 0.1c 1.04 ± 0.14d 1.83 ± 1.17cd 0.51 ± 0.05b 0.97 ± 0.07cd
Note: Data are presented as means ± SEM of three replicates. Different alphabets indicate significantly different groupings following Duncan post hoc comparison
of each column (p < 0.05). Relative expression (ΔΔCq) was calculated by normalizing to the reference gene (GAPDH) and negative controls
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response in mice [35]. Hence, it is essential to further
evaluate the importance of this finding in FIP cats.
Earlier studies have proposed that the fundamental
difference in the immune profiles of dry and wet
forms of FIP is based on the predominant T cell
responses. Cats with the dry form of FIP have a
higher number of Th1 cells for the induction of CMI
response, while cats with the wet form of FIP gener-
ally showed Th2-type response that leads to humoral
immune response [13, 19].
The majority of FIP cases involve the presence of
abdominal effusion, which was observed in eight out
of 15 FCoV-positive cats sampled in this study [2].
Based on the pathogenesis of FIP, the accumulation of
fluids in the peritoneal cavity of these cats is most
probably due to the accumulation of the infected
macrophages in the inter-venular space and venule
walls [1, 10]. Activated and FCoV-infected monocytes
can induce phlebitis through the paracrine and auto-
crine action of CD18, IL-1β and TNFα [11]. In
addition, higher secretion of vascular endothelial
growth factor (VEGF) has been associated with an in-
creased production of effusion in cats with FIP [36].
Also, studies have shown that PE of cats diagnosed
with FIP consisted primarily of macrophages and neu-
trophils with a low number of lymphocytes [37]. This
study is in agreement with another study that re-
ported a higher viral load in the supernatants of PE
compared to those derived from the blood component
of affected cats (Table 6) [15]. In addition, as
expected, this study detected high expression of pro-
inflammatory cytokines and chemokines, namely GM-
CSF, IFNγ, IL8, KC, RANTES and MCP1, which are
secreted mainly by monocytes/macrophages. The
detection of CCL17 in the cell component of PE but
not in PBMC indicated the inflammatory nature of
the activated cells such as macrophages and dendritic
cells (DC) present in the PE which may play an im-
portant role in the activation of Th2 cells [38, 39].
Furthermore, the lack of CCL17 expression, a chemo-
kine that is primarily expressed in Th2 cells of cats
with allergic inflammation [40], in the PBMC of the
cats sampled in this study suggests a local rather than
systemic response to the virus as also observed in
other studies [17, 41, 42]. Further studies are
warranted to confirm the expression of CCL17 by the
activated cells from the PE of FIP cats. In addition,
the downregulation of SCF (Table 9) is probably asso-
ciated with the reduction of DC in cats with FIP,
since SCF and Flt-3 L are important cytokines for the
ex vivo propagation of human and mice DC [43, 44].
It was known that DC could be infected by FCoV;
however, the role of SCF and Flt-3 L in FIPV infec-
tion warrants further examination [45].
In this study, the immune mediator protein levels
vary between individual cats within the different co-
horts (Tables 9 and 10). These findings were expected
as biological individual variation could occur and has
been observed in several other natural and experi-
mental FIPV infections [12, 19]. Nevertheless, the
expression of pro-inflammatory cytokines, namely
IL1β and IL6, was more readily detected in the PES
rather than the serum of the cats diagnosed with FIP.
This finding is in agreement with previous studies
that showed IL1 and IL6 can be detected in the
serum and PE of FIP cases but not in those of
healthy cats [18]. Besides, previous studies have
shown that IL1β is related to CNS involvement and
can only be detected in the inflammatory cells in the
brain [19]. In this study, we found that IL-18, a pro-
inflammatory cytokine in the IL-1 family that plays a
major role in the activation of NK and T cells [46],
was not readily detected in both serum and PES. The
upregulation of TNFα protein in the serum and PES
of some of the cats was in line with findings by
previous studies that detected an increase in TNFα
mRNA in abdominal effusions and PBMC of FIP-
positive cats [14]. In addition, it has been suggested
that this cytokine is responsible for T cell apoptosis
[14, 21]. Hence, the role of these cytokines in FCoV-
positive cats requires further evaluation. Interestingly,
most of the FCoV-positive cats in this study have
increased Fas serum levels, which may suggest a
possible role of Fas in T cell apoptosis observed in
FIP, as apoptosis can be induced by overexpression of
Fas during viral infection [47].
Conclusions
In conclusion, this study has established some insights
on the different expression of immune mediators in
FCoV-positive cats, where several immune mediators in-
cluding pro-inflammatory cytokines, Th1-like cytokines,
and IFN-related antiviral proteins were found to be
highly expressed. In addition, no clear indication of Th1
and Th2 imbalance was detected in the various samples
analyzed in this study. However, in general, MX1,
viperin, CXCL10, CCL8, RANTES, KC, MCP1, IL8,
GM-CSF and IFNγ were readily detected in FCoV-
positive cats whereby MX1 and viperin expression was
higher in FCoV-positive cats with peritoneal effusions.
Future studies on FIP confirmed cases need to be carried
out to further establish the importance of the different
immune mediators in the development of FIP.
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